Evercore ISI Cuts Teladoc Health (NYSE:TDOC) Price Target to $14.00

Teladoc Health (NYSE:TDOC) had its price objective dropped by Evercore ISI from $15.00 to $14.00 in a report released on Friday, Benzinga reports. The firm currently has an “in-line” rating on the health services provider’s stock. Evercore ISI’s target price indicates a potential upside of 6.14% from the company’s current price.

Several other equities analysts have also weighed in on the company. Barclays reduced their price objective on Teladoc Health from $25.00 to $20.00 and set an “overweight” rating for the company in a report on Friday. Stifel Nicolaus dropped their price objective on Teladoc Health from $21.00 to $16.00 and set a “hold” rating for the company in a research note on Friday. Leerink Partnrs reissued a “market perform” rating on shares of Teladoc Health in a research note on Monday, February 26th. Piper Sandler dropped their price objective on Teladoc Health from $30.00 to $25.00 and set an “overweight” rating for the company in a research note on Wednesday, February 21st. Finally, Canaccord Genuity Group lowered their price target on Teladoc Health from $28.00 to $25.00 and set a “buy” rating on the stock in a research report on Friday. Eleven equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $20.00.

Teladoc Health Stock Down 1.1 %

TDOC stock traded down $0.14 during trading on Friday, reaching $13.19. 4,457,614 shares of the stock were exchanged, compared to its average volume of 4,756,420. The firm’s 50 day moving average is $15.17 and its 200 day moving average is $17.80. Teladoc Health has a twelve month low of $12.65 and a twelve month high of $30.41. The company has a current ratio of 3.54, a quick ratio of 3.47 and a debt-to-equity ratio of 0.66. The firm has a market cap of $2.23 billion, a P/E ratio of -9.89 and a beta of 0.94.

Teladoc Health (NYSE:TDOC) last issued its quarterly earnings data on Thursday, April 25th. The health services provider reported ($0.49) EPS for the quarter, missing the consensus estimate of ($0.47) by ($0.02). The company had revenue of $646.13 million during the quarter, compared to analysts’ expectations of $637.31 million. Teladoc Health had a negative return on equity of 9.22% and a negative net margin of 8.47%. The business’s revenue for the quarter was up 2.7% compared to the same quarter last year. During the same period last year, the company earned ($0.37) earnings per share. As a group, research analysts forecast that Teladoc Health will post -1.07 EPS for the current year.

Insider Buying and Selling

In other Teladoc Health news, EVP Andrew Turitz sold 6,190 shares of the stock in a transaction dated Monday, March 4th. The shares were sold at an average price of $14.52, for a total transaction of $89,878.80. Following the completion of the transaction, the executive vice president now owns 39,429 shares of the company’s stock, valued at approximately $572,509.08. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, EVP Andrew Turitz sold 6,190 shares of the company’s stock in a transaction dated Monday, March 4th. The shares were sold at an average price of $14.52, for a total transaction of $89,878.80. Following the sale, the executive vice president now directly owns 39,429 shares in the company, valued at approximately $572,509.08. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CAO Richard J. Napolitano sold 3,765 shares of the stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $14.52, for a total transaction of $54,667.80. Following the completion of the sale, the chief accounting officer now directly owns 18,077 shares in the company, valued at $262,478.04. The disclosure for this sale can be found here. In the last quarter, insiders sold 135,441 shares of company stock valued at $2,038,251. Company insiders own 1.63% of the company’s stock.

Hedge Funds Weigh In On Teladoc Health

Hedge funds and other institutional investors have recently modified their holdings of the business. Newbridge Financial Services Group Inc. boosted its stake in Teladoc Health by 2,130.9% in the first quarter. Newbridge Financial Services Group Inc. now owns 11,400 shares of the health services provider’s stock valued at $172,000 after acquiring an additional 10,889 shares in the last quarter. Westside Investment Management Inc. boosted its stake in Teladoc Health by 37.7% in the first quarter. Westside Investment Management Inc. now owns 5,662 shares of the health services provider’s stock valued at $85,000 after acquiring an additional 1,550 shares in the last quarter. Allspring Global Investments Holdings LLC boosted its stake in Teladoc Health by 74.0% in the first quarter. Allspring Global Investments Holdings LLC now owns 20,568 shares of the health services provider’s stock valued at $311,000 after acquiring an additional 8,750 shares in the last quarter. Counterpoint Mutual Funds LLC acquired a new stake in Teladoc Health in the first quarter valued at approximately $271,000. Finally, Ignite Planners LLC boosted its stake in Teladoc Health by 6.9% in the first quarter. Ignite Planners LLC now owns 13,307 shares of the health services provider’s stock valued at $198,000 after acquiring an additional 857 shares in the last quarter. 76.82% of the stock is currently owned by institutional investors.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.